Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection

Isitman G, Chung AW, Navis M, Kent SJ, Stratov I

(2011), Virology, 412(1), 110-6

Screening and confirmatory testing of MHC class I alleles in pig-tailed macaques

Fernandez CS, Reece JC, Saepuloh U, De Rose R, Ishkandriati D, O'Connor DH, Wiseman RW, Kent SJ

(2011), Immunogenetics, 63(8), 511-21

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

Chung AW, Isitman G, Navis M, Kramski M, Center RJ, Kent SJ, Stratov I

(2011), Proc Natl Acad Sci USA, 108(18), 7505-10

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L

(2011), Viral Immunol, 24(5), 359-68

Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques

Queen SE, Mears BM, Kelly KM, Dorsey JL, Liao Z, Dinoso JB, Gama L, Adams RJ, Zink MC, Clements JE, Kent SJ, Mankowski JL

(2011), J Virol, 85(17), 9167-75

Activation of NK cells by ADCC antibodies and HIV disease progression

Chung AW, Navis M, Isitman G, Wren L, Silvers J, Amin J, Kent SJ, Stratov I

(2011), J Acquir Immune Defic Syndr, 58(2), 127-31

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy R, Neaton JD; INSIGHT SMART Study Group

(2011), AIDS, 25(17), 2133-42

Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD

Choi JY, Zhou J, Giles M, Broom J, Templeton DJ, Law MG, Chaiwarith R, Tanuma J; Asia-Pacific HIV Observational Database

(2011), J Acquir Immune Defic Syndr, 57(1), e13-5

Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant

McCarthy FP, Giles ML, Rowlands S, Purcell KJ, Jones CA

(2011), Cochrane Database Syst Rev, (3), CD008371

CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts

Wright ST, Carr A, Woolley I, Giles M, Hoy J, Cooper DA, Law MG; Australian HIV Observational Database

(2011), J Acquir Immune Defic Syndr, 58(1), 72-9

Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding

Giles M, Visvanathan K, Sasadeusz J

(2011), Antivir Ther, 16(5), 621-8

HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans

Wadley AL, Cherry CL, Price P, Kamerman PR

(2011), J Pain Symptom Manage, 41(4), 700-6

Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals

Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, Jaworowski A, Crowe SM

(2011), PLoS One, 6(5), e19968

Plasma levels of soluble CD14 independently predict mortality in HIV infection

Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, Neaton JD, Brenchley JM, Deeks SG, Sereti I, Douek DC; INSIGHT SMART Study Group

(2011), J Infect Dis, 203(6), 780-90

Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells

Saleh S, Wightman F, Ramanayake S, Alexander M, Kumar N, Khoury G, Pereira C, Purcell D, Cameron PU, Lewin SR

(2011), Retrovirology, 8, 80

HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism

Roche M, Jakobsen MR, Sterjovski J, Ellett A, Posta F, Lee B, Jubb B, Westby M, Lewin SR, Ramsland PA, Churchill MJ, Gorry PR

(2011), J Virol, 85(9), 4330-42

HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry

Roche M, Jakobsen MR, Ellett A, Salimiseyedabad H, Jubb B, Westby M, Lee B, Lewin SR, Churchill MJ, Gorry PR

(2011), Retrovirology, 8, 89

Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database

Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, Cameron PU, Petoumenos K, Lewin SR

(2011), PLoS One, 6(6), e20713

HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage study

Pierce AB, Yohannes K, Guy R, Watson KM, Armishaw J, Price B, Hoy JF, Wright EJ, Stoové MA

(2011), Sex Health, 8(2), 179-83

Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies

Morrissey CO, Chen SC, Sorrell TC, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Schwarer AP, Slavin MA

(2011), Leuk Lymphoma, 52(2), 179-93

49 50 51 52 53